comparemela.com

Page 2 - Martin Pierre Laurent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

THERANEXUS, BBDF AND CARDIFF UNIVERSITY PRESENT THEIR NOVEL RESEARCH ON BATTEN-1 AND BATTEN DISEASE AT WORLDSYMPOSIUM 2023

From 22 to 26 February 2023 in Orlando, Florida Presentation of preclinical data demonstrating how Batten-1 drastically reduces the buildup of toxic glycosphingolipids in Batten disease and a poster

United statesFrance generalUnited kingdomDennis riedlCraig bensonEmyr lloyd evansThierry lambertMathieu charvFlorence portejoieMartin pierre laurentCharles evansNational organization for rare disordersHannah best of cardiff universityCardiff universityAtomic energy commissionBatten disease foundation

AISTROSIGHT: NEW JOINT PROJECT TEAM BETWEEN THERANEXUS, INRIA, CLAUDE BERNARD UNIVERSITY LYON 1 AND HOSPICES CIVILS DE LYON TARGETING RARE NEUROLOGICAL DISEASES

Lyon, France - 10 February 2023 - 7.30am CET - Theranexus, Inria, Claude Bernard University Lyon 1 and Hospices Civils de Lyon today announced the launch of the new public-private project team "AlstroSight".

France generalThomas lacondemineBruno sportisseClaude bernard lyonSchwierige zeitenLaurence goussuRaymond le moignThierry lambertFlorence portejoieMartin pierre laurentFranck mouthonMinistry of higher educationHealth acceleration strategyClaude bernard university lyonMinistry of healthAtomic energy commission

THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2022 AND ANNOUNCES ORGANIZATIONAL CHANGES

Lyon, France - 18 January 2023 - 7.30am CET - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating

France generalThierry lambertInserm transfertMathieu charvFranck mouthon mathieuFlorence portejoieMartin pierre laurentFrench national institute of healthAtomic energy commissionResearch insermFranck mouthonTheranexus executive chairmanFrench national instituteMedical researchFrench alternative energiesEuronext growth

THERANEXUS: New advance to the Theranexus and BBDF Batten-1 program for juvenile Batten disease (CLN3)

Lyon, France - Austin, Texas, United States - 5 January 2023 - 6.00 pm CET - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development

United statesFrance generalSan franciscoCraig bensonThierry lambertMarie sebilleFlorence portejoieMartin pierre laurentNational organization for rare disordersNeuroscience innovation forumAtomic energy commissionBatten disease foundationSachs associatesBeyond batten disease foundationTheranexu chief medical officer marie sebilleAnnual neuroscience innovation forum

New Advance to the Theranexus and BBDF Batten-1 Program for Juvenile Batten Disease

LYON, FRANCE and AUSTIN, TX / ACCESSWIRE / January 5, 2023 / Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates

United statesFrance generalSan franciscoCraig bensonThierry lambertMarie sebilleFlorence portejoieMartin pierre laurentNational organization for rare disordersNeuroscience innovation forumAtomic energy commissionBatten disease foundationSachs associatesBeyond batten disease foundationTheranexu chief medical officer marie sebilleAnnual neuroscience innovation forum

vimarsana © 2020. All Rights Reserved.